Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 16, 2021
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations
Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, et al.
International Journal of Molecular Medicine
|
December 16, 1998
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines
J J Yu, C Mu, M Dabholkar, et al.
The Indian Journal of Radiology & Imaging
|
January 12, 2026
Establishing Diagnostic Reference Level for Adult Abdomen and Pelvis CT Scans: A Benchmarking Study across BMI Groups
Jaseemudheen M M, Raghuraja U, Sri Krishna U, et al.
Mutation Research
|
January 1, 1993
Expression of excision repair genes in non-malignant bone marrow from cancer patients
M Dabholkar, F Bostick-Bruton, C Weber, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1993
Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells
R J Parker, M D Dabholkar, K B Lee, et al.
Journal of the National Cancer Institute
|
October 7, 1992
ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients
M Dabholkar, F Bostick-Bruton, C Weber, et al.
Biochemical Pharmacology
|
November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues
M Dabholkar, K Thornton, J Vionnet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 30, 2021
Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach
Tejashree Waghule, Neha Dabholkar, Srividya Gorantla, et al.
International Journal of Oncology
|
May 6, 2011
Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPA
J Yu, M Dabholkar, W Bennett, et al.
Oncology Reports
|
August 19, 2000
Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues
E Reed, M Dabholkar, K Thornton, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 16, 2021
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations
Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, et al.
International Journal of Molecular Medicine
|
December 16, 1998
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines
J J Yu, C Mu, M Dabholkar, et al.
The Indian Journal of Radiology & Imaging
|
January 12, 2026
Establishing Diagnostic Reference Level for Adult Abdomen and Pelvis CT Scans: A Benchmarking Study across BMI Groups
Jaseemudheen M M, Raghuraja U, Sri Krishna U, et al.
Mutation Research
|
January 1, 1993
Expression of excision repair genes in non-malignant bone marrow from cancer patients
M Dabholkar, F Bostick-Bruton, C Weber, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1993
Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells
R J Parker, M D Dabholkar, K B Lee, et al.
Journal of the National Cancer Institute
|
October 7, 1992
ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients
M Dabholkar, F Bostick-Bruton, C Weber, et al.
Biochemical Pharmacology
|
November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues
M Dabholkar, K Thornton, J Vionnet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 30, 2021
Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach
Tejashree Waghule, Neha Dabholkar, Srividya Gorantla, et al.
International Journal of Oncology
|
May 6, 2011
Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPA
J Yu, M Dabholkar, W Bennett, et al.
Oncology Reports
|
August 19, 2000
Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues
E Reed, M Dabholkar, K Thornton, et al.
Page
of 14